PRKACB is downregulated in nonsmall cell lung cancer and exogenous PRKACB inhibits proliferation and invasion of LTEPA2 cells
Publisher: Spandidos Publications
ISSN: 1792-1074
Source: Oncology Letters, Vol.5, Iss.6, 2013-01, pp. : 1803-1808
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract